Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FRRL2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,110
Award facts
- Contract value 100% obligated
- $10,110.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,110 to DMS Pharmaceutical Group Inc. on January 9, 2026, for the supply of EYLEA HD 8 mg/0.07 mL vials. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in distributing pharmaceutical products and medical consumables to federal agencies. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award carries an ultimate completion date of February 2, 2026, and is funded by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group Inc.'s Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 with an ultimate completion date of December 31, 2036, was awarded on November 13, 2025, and authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FRRL2?
SPE2DR26FRRL2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FRRL2 worth?
The government has obligated $10,110 on SPE2DR26FRRL2.
Is contract SPE2DR26FRRL2 an order under another contract?
Yes. SPE2DR26FRRL2 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRL2 competed?
The extent of competition for SPE2DR26FRRL2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award